Thomas Marbury
Nephrology · Orlando, FLNPI 1689734311
Payments from drug & device makers
What this record shows
That places this record below the midpoint for nephrology clinicians in FL, where the typical reported total is $1,407.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$41,195,107in research payments, 2019–2025
Across 2,699 payments — averaging $15,263 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$4.1M
- Incyte Corporation$2.8M
- Amgen$2.6M
- E.r. Squibb & Sons, L.L.C.$2.6M
- Takeda Pharmaceuticals U.S.A., Inc.$2M
- Bristol Myers Squibb$1.9M
- plus $25.1M from 54 others
How this compares
$0 in reported general payments places this provider in the 0th percentile of 756 nephrology providers in Florida.
Other nephrology in Orlando
- Arvind MadanOrlando$943K
- Paul DreyerOrlando$40K
- Jorge KourieOrlando$39K
- Shivam JoshiOrlando$33K
- Fawad AhmedOrlando$14K
- John CopleyWeston$934K
- Jorge LarranagaKissimmee$825K
- Carlos BejarFort Lauderdale$530K
- Wayne KotzkerFort Lauderdale$472K
- Jason RothschildTemple Terrace$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.